Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination [kombinace léků sitagliptin a metformin]
topical
50
- Terms
-
fixní kombinace fosfátu sitagliptinu a hydrochloridu metforminu
Janumet
-
Janumet
Sitagliptin Phosphate Metformin Hydrochloride Drug Combination
Sitagliptin Phosphate-Metformin Hydrochloride Drug Combination
Persistent link
https://www.medvik.cz/link/D000068899
Definition
A pharmaceutical preparation of sitagliptin phosphate and metformin hydrochloride that is used in the treatment of TYPE 2 DIABETES.
- DUI
- D000068899 MeSH Browser
- CUI
- M000604087
- History note
- 2016 (2008)
- Public note
- 2016; SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE DRUG COMBINATION was indexed under METFORMIN and PYRAZINES 2008-2015
Allowable subheadings
- AD
- administration & dosage 23
- AE
- adverse effects 16
- AG
- agonists
- AA
- analogs & derivatives
- AI
- antagonists & inhibitors 1
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 2
- PK
- pharmacokinetics 1
- PD
- pharmacology 13
- PO
- poisoning
- RE
- radiation effects
- ST
- standards 1
- SD
- supply & distribution
- TU
- therapeutic use 32
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D26.310.344
Albuterol, Ipratropium Drug Combination
D26.310.391
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
D26.310.454
Lidocaine, Prilocaine Drug Combination
D26.310.813
Tobramycin, Dexamethasone Drug Combination